Gene · 4256
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Osteoarthritis year in review 2024: Genetics, genomics, and epigenetics. | Osteoarthritis Cartilage | 2025 | 39537019 | PubTator, text mining | PubMed |
| Matrix Gla protein suppresses osteoblast senescence and promotes osteogenic differentiation by the PI3K-AKT signaling pathway. | Exp Cell Res | 2025 | 39536932 | PubTator, text mining | PubMed |
| The associations between functional vitamin K status and all-cause mortality, cardiovascular disease and end-stage kidney disease in persons with type 1 diabetes. | Diabetes Obes Metab | 2025 | 39434445 | PubTator, text mining | PubMed |
| Deciphering Breast Origin in Malignant Effusions: The Diagnostic Utility of an MGP, GATA-3, and TRPS-1 Immunocytochemical Panel. | Pathobiology | 2025 | 39191231 | PubTator, text mining | PubMed |
| Associations of Indoxyl Sulfate and p-cresyl Sulfate with Serum Uncarboxylated Matrix γ-carboxyglutamate Protein in Chronic Kidney Disease Patients. | Curr Med Chem | 2025 | 38231071 | PubTator, text mining | PubMed |
| Vitamin K-Dependent Proteins as Predictors of Valvular Calcifications and Mortality in Hemodialysis Patients. | Biomedicines | 2024 | 39857632 | PubTator, text mining | PubMed |
| Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications. | Int J Mol Sci | 2024 | 39684805 | PubTator, text mining | PubMed |
| Transcriptional Regulation of the Human MGP Promoter: Identification of Downstream Repressors. | Int J Mol Sci | 2024 | 39684309 | PubTator, text mining | PubMed |
| PIVKA-II but not dp-ucMGP is associated with aortic calcification in chronic kidney disease. | BMC Nephrol | 2024 | 39604863 | PubTator, text mining | PubMed |
| The Roles of Vitamin D Levels, Gla-Rich Protein (GRP) and Matrix Gla Protein (MGP), and Inflammatory Markers in Predicting Mortality in Intensive Care Patients: A New Biomarker Link? | Metabolites | 2024 | 39590856 | PubTator, text mining | PubMed |
| Investigating the associations between uncarboxylated matrix gla protein as a proxy for vitamin K status and cardiovascular disease risk factors in a general adult population. | Eur J Nutr | 2024 | 39567396 | PubTator, text mining | PubMed |
| An inducible model for medial calcification based on matrix Gla protein deficiency. | J Struct Biol | 2024 | 39461577 | PubTator, text mining | PubMed |
| Enhancing spatial domain detection in spatial transcriptomics with EnSDD. | Commun Biol | 2024 | 39433947 | PubTator, text mining | PubMed |
| Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity-An Italian Study. | J Clin Med | 2024 | 39407947 | PubTator, text mining | PubMed |
| The role of DNA methylation in chondrogenesis of human iPSCs as a stable marker of cartilage quality. | Clin Epigenetics | 2024 | 39407288 | PubTator, text mining | PubMed |
| Inorganic pyrophosphate plasma levels in patients with GGCX-associated PXE-like phenotypes. | Front Genet | 2024 | 39399214 | PubTator, text mining | PubMed |
| Two Members of Vitamin-K-Dependent Proteins, Gla-Rich Protein (GRP) and Matrix Gla Protein (MGP), as Possible New Players in the Molecular Mechanism of Osteoarthritis. | J Clin Med | 2024 | 39274372 | PubTator, text mining | PubMed |
| Matrix Gla Protein and Nitric Oxide Synthase-3 Genetic Variants in Chronic Kidney Disease and Their Relation with Cardiovascular Risk. | Int J Nephrol | 2024 | 39246453 | PubTator, text mining | PubMed |
| Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing. | Front Immunol | 2024 | 39224598 | PubTator, text mining | PubMed |
| Time- and cell-specific activation of BMP signaling restrains chondrocyte hypertrophy. | iScience | 2024 | 39193188 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4256/papers?page=6